MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 241 filers reported holding MYOKARDIA INC in Q2 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $21,263,000 | +59.5% | 155,972 | +13.0% | 0.20% | +41.8% |
| Q2 2020 | $13,334,000 | +165.5% | 138,000 | +95.7% | 0.14% | +151.8% |
| Q1 2020 | $5,023,000 | -2.2% | 70,500 | 0.0% | 0.06% | +1.8% |
| Q4 2019 | $5,138,000 | +61.5% | 70,500 | +15.6% | 0.06% | +31.0% |
| Q3 2019 | $3,181,000 | +4.5% | 61,000 | 0.0% | 0.04% | +10.5% |
| Q2 2019 | $3,045,000 | -4.0% | 61,000 | 0.0% | 0.04% | -7.3% |
| Q1 2019 | $3,172,000 | +6.4% | 61,000 | 0.0% | 0.04% | -10.9% |
| Q4 2018 | $2,980,000 | -25.1% | 61,000 | 0.0% | 0.05% | -13.2% |
| Q3 2018 | $3,977,000 | +31.3% | 61,000 | 0.0% | 0.05% | +10.4% |
| Q2 2018 | $3,029,000 | +1.7% | 61,000 | 0.0% | 0.05% | -5.9% |
| Q1 2018 | $2,977,000 | -27.8% | 61,000 | -37.8% | 0.05% | -28.2% |
| Q4 2017 | $4,126,000 | -9.2% | 98,000 | -7.5% | 0.07% | -10.1% |
| Q3 2017 | $4,542,000 | – | 106,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 399,360 | $38,586,000 | 34.31% |
| Copernicus Capital Management, LLC | 57,000 | $5,507,000 | 6.04% |
| Foresite Capital Management IV, LLC | 126,492 | $12,222,000 | 5.95% |
| Casdin Capital, LLC | 870,000 | $84,059,000 | 4.98% |
| Avoro Capital Advisors LLC | 1,880,000 | $181,646,000 | 3.59% |
| RTW INVESTMENTS, LP | 936,931 | $90,526,000 | 2.55% |
| Cormorant Asset Management, LP | 600,000 | $57,972,000 | 2.21% |
| Perceptive Advisors | 1,395,017 | $134,787,000 | 2.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 65,859 | $6,372,000 | 2.12% |
| Grace Capital | 24,400 | $2,358,000 | 2.02% |